ACE2-IgM-Fc FUSION PROTEINS AND USES THEREOF
US-2024307512-A1 · Sep 19, 2024 · US
US11473073B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11473073-B2 |
| Application number | US-201615574323-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 27, 2016 |
| Priority date | Jun 26, 2015 |
| Publication date | Oct 18, 2022 |
| Grant date | Oct 18, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure provides polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. In some embodiments, the disclosure also provides to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides. In some embodiments, the present disclosure further provides to methods of obtaining protein hydrolysates useful as flavor improving agents.
Opening claim text (preview).
The invention claimed is: 1. A method for the production of a protein hydrolysate comprising subjecting a proteinaceous substrate, wherein the substrate is selected from the group consisting of casein, whey protein isolate, soy protein isolate and gluten, to a purified polypeptide having aminopeptidase activity, selected from the group consisting of: (a) a polypeptide having an amino acid sequence comprising the amino acid sequence of SEQ ID NO: 1, or SEQ ID NO: 2, or SEQ ID NO: 3, or SEQ ID NO: 4, or SEQ ID NO: 5, or SEQ ID NO: 6, or SEQ ID NO: 7, or SEQ ID NO: 8; and (b) a fragment of (a), wherein the fragment has aminopeptidase activity. 2. The method of claim 1 , further comprising subjecting said proteinaceous substrate to an endopeptidase. 3. The method of claim 2 , wherein the hydrolysate is enriched in Leu, Gly, Glu, Ser, Asp, Asn, Pro, Cys, Ala, and/or Gln. 4. The method of claim 2 , wherein the hydrolysate is enriched in Glu and/or Gln. 5. A method for obtaining from a proteinaceous substrate a protein hydrolysate enriched in free glutamic acid and/or peptide bound glutamic acid residues, comprising subjecting the substrate to a deamidation process and a purified polypeptide having aminopeptidase activity, selected from the group consisting of: (a) a polypeptide having an amino acid sequence comprising the amino acid sequence of SEQ ID NO: 1, or SEQ ID NO: 2, or SEQ ID NO: 3, or SEQ ID NO: 4, or SEQ ID NO: 5, or SEQ ID NO: 6, or SEQ ID NO: 7, or SEQ ID NO: 8; and (b) a fragment of (a), wherein the fragment has aminopeptidase activity. 6. The method of claim 5 , further comprising subjecting the substrate to one or more unspecific acting endo- and/or exo-peptidase enzymes.
Enzymes · CPC title
Exopeptidases (3.4.11-3.4.19) · CPC title
containing a signal sequence · CPC title
Aminopeptidases (3.4.11) · CPC title
Influencing the germination by chemical or physical means · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.